Karimi Saeed, Arabi Amir, Ansari Iman, Shahraki Toktam, Safi Sare
Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Ophthalmology, Torfeh Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Ophthalmol. 2021 Feb 26;2021:5553885. doi: 10.1155/2021/5553885. eCollection 2021.
Traumatic optic neuropathy (TON) is an uncommon vision-threatening disorder that can be caused by ocular or head trauma and is categorized into direct and indirect TON. The overall incidence of TON is 0.7-2.5%, and indirect TON has a higher prevalence than direct TON. Detection of an afferent pupillary defect in the presence of an intact globe in a patient with ocular or head trauma with decreased visual acuity strongly suggests TON. However, afferent pupillary defects may be difficult to detect in patients who have received narcotics that cause pupillary constriction and in those with bilateral TON. Mechanical shearing of the optic nerve axons and contusion necrosis due to immediate ischemia from damage to the optic nerve microcirculation and apoptosis of neurons is a probable mechanism. The proper management of TON is controversial. High-dose corticosteroid therapy and decompression of the optic nerve provide no additional benefit over observation alone. Intravenous erythropoietin may be a safe and efficient treatment for patients with TON.
创伤性视神经病变(TON)是一种罕见的、威胁视力的疾病,可由眼部或头部外伤引起,分为直接性和间接性TON。TON的总体发病率为0.7%-2.5%,间接性TON的患病率高于直接性TON。在视力下降的眼部或头部外伤患者中,若眼球完整但存在传入性瞳孔障碍,则强烈提示TON。然而,在使用了导致瞳孔收缩的麻醉药物的患者以及双侧TON患者中,传入性瞳孔障碍可能难以检测。视神经轴突的机械性剪切以及由于视神经微循环损伤导致的即刻缺血引起的挫伤性坏死和神经元凋亡是可能的机制。TON的恰当治疗存在争议。大剂量皮质类固醇疗法和视神经减压与单纯观察相比并无额外益处。静脉注射促红细胞生成素可能是TON患者的一种安全有效的治疗方法。